Skip to content

Meditation, Yoga, and the Journey to Parenthood: Can They Improve IVF Results?

A Mindful Path to Parenthood: Evaluating the Impact of Preksha Meditation and Yoga on IVF Outcomes in Infertile Couples - An Open-Label Randomized Controlled Trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096046
Enrollment
140
Registered
2025-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Yoga and meditation and Conventional treatment for 12 weeks: 12 weeks Control Intervention1: Conventional infertility treatment: 12 weeks

Sponsors

All India Institute Of Medical Sciences, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Mild male factor infertility, anovulation, unexplained infertility, PCOS, tubal factor. 2. Currently seeking fertility treatment at AIIMS, New Delhi. 3. No prior experience with yoga or meditation. 4. Female partner has a BMI less than or qual to 30. 5. No significant medical comorbidities.

Exclusion criteria

Exclusion criteria: 1. Not willing to give written informed consent 2. Medical or surgical contraindications to yoga 3. Inability to commit to regular yoga and meditation sessions 4. Morbid obesity in woman 5. Severe endometriosis 6. Prior ovarian surgeries 7. Diabetes Mellitus 8. Autoimmune disorder

Design outcomes

Primary

MeasureTime frame
To assess the impact of yoga and meditation on stress and anxiety in infertile couples undergoing IVF.Timepoint: Psychological distress will be measured using the DASS-21 and ERQ at Baseline (Week 0) and at end of intervention i.e., 12 week

Secondary

MeasureTime frame
A. To evaluate the effect of yoga on reproductive health markers in women, including menstrual cycle regularity, ovulation, follicular development, & endometrial thickness. B. To assess changes in male fertility parameters, including semen quality & biochemical markers. C. To measure improvements in IVF outcomes, including: 1. number an quality of oocytes, 2. embryo number, 3. fertilization rate, 4. implantation rate, & 5. clinical pregnancy rate. Timepoint: Timepoints: Baseline (Week 0) & at end of intervention i.e., 12 week IVF success indicators, including oocyte quality, embryo grading, & pregnancy rates, will be monitored over 12 weeks. Statistical analysis (Python, ANOVA, regression modeling) will determine the efficacy of the intervention.

Countries

India

Contacts

Public ContactDr Neeta Singh

All India Institute of Medical Sciences, Delhi

drneetasingh@yahoo.com9818506855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026